XRF ScientificASX:XRF -1.96%100 Current Ratio is 6.71 as of Dec. 2025, which is 121% above its 10-year median of 3.03. GuruFocus rates ASX:XRF with a GF Score™ of 100/100 and a GF Value™ of A$1.65 (Fairly Valued). The stock has 1 warning sign investors should review. Among 561 Conglomerates companies, XRF Scientific ranks better than 92.69% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. XRF Scientific's current ratio for the quarter that ended in Dec. 2025 was 6.71.
XRF Scientific has a current ratio of 6.71. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for XRF Scientific's Current Ratio or its related term are showing as below:
ASX:XRF'
s Current Ratio Range Over the Past 10 Years
Min: 2.4 Med: 3.03 Max: 6.71
Current: 6.71
During the past 13 years, XRF Scientific's highest Current Ratio was 6.71. The lowest was 2.40. And the median was 3.03.
ASX:XRF's Current Ratio is ranked better than 92.69% of 561
companies
in the Conglomerates industry
Industry Median: 1.6
vs ASX:XRF: 6.71
XRF Scientific (ASX:XRF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
XRF Scientific Current Ratio Related Terms
XRF Scientific Current Ratio Historical Data
* Premium members only.
The historical data trend for XRF Scientific's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, XRF Scientific's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific Current Ratio vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's Current Ratio distribution charts can be found below:
* The bar in red indicates where XRF Scientific's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRF Scientific (ASX:XRF) has a Current Ratio of 6.71 as of Dec. 2025. This is 121% above median its historical median of 3.03. Over the past decade, XRF Scientific's Current Ratio has ranged from 2.40 to 6.71. According to the industry distribution chart, XRF Scientific ranks #41 out of 561 companies in the Conglomerates industry, placing it in the top 7.3%.
Is XRF Scientific's Current Ratio too high?
XRF Scientific's current Current Ratio of 6.71 is 121% above median its 10-year median of 3.03. Over the past 10 years, this metric has ranged from a low of 2.40 to a high of 6.71. The Conglomerates industry median Current Ratio is 1.60. XRF Scientific's value of 6.71 is 319.4% above this industry median. Based on the distribution chart, XRF Scientific ranks #41 out of 561 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, XRF Scientific has a GF Score™ of 100/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's Current Ratio compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #41 out of 561 companies for Current Ratio. This places XRF Scientific in the top 7% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.60. XRF Scientific's value of 6.71 is 319.4% above this benchmark. Historically, XRF Scientific's own Current Ratio has ranged from 2.40 to 6.71 over the past decade. While the company's 10-year median is 3.03 vs. the industry median of 1.60, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Conglomerates company?
The median Current Ratio among Conglomerates companies is 1.60, based on 561 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current Current Ratio of 6.71 is 319.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Conglomerates industry, the median Current Ratio is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current Current Ratio is 6.71, which is 121% above median its own 10-year median of 3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.75 — trading 6.1% above its estimated fair value. The current Current Ratio is 6.71, which is 121% above median its 10-year median of 3.03 and 319.4% above the Conglomerates industry median of 1.60. XRF Scientific's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current Current Ratio is 6.71 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.75 is trading 6.1% above its estimated GF Value™ of A$1.65.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
Current Ratio: 6.71 (121% above median its 10-year median of 3.03)
GF Value™: A$1.65 vs. price of A$1.75 (6.1% above fair value)
Industry Position: 319.4% above the Conglomerates median (#41 of 561)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
100GF Score
Get the complete analysis for ASX:XRF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
